| Dr Gabriel Jacobs, MD | |
|
911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 | |
| (606) 430-3500 | |
| (606) 437-1033 |
| Full Name | Dr Gabriel Jacobs |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 16 Years |
| Location | 911 Bypass Rd Bldg A, Pikeville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063647477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 57.015011 (Ohio) | Secondary |
| 207L00000X | Anesthesiology | TP659 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pikeville Medical Center | Pikeville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pikeville Medical Center Inc | 6709790157 | 314 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
| Entity Name | Commonwealth Anesthesia, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437196300 PECOS PAC ID: 5092627521 Enrollment ID: O20031104000115 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
| Entity Name | Pikeville Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528195864 PECOS PAC ID: 6709790157 Enrollment ID: O20040304001281 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
| Entity Name | Riverside Anesthesia Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578946596 PECOS PAC ID: 3072828193 Enrollment ID: O20150819007441 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
| Entity Name | Anesthesia Health Consultants |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336528926 PECOS PAC ID: 4688977218 Enrollment ID: O20160114001985 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gabriel Jacobs, MD Po Box 432, Pikeville, KY 41502-0432 Ph: (606) 430-3500 | Dr Gabriel Jacobs, MD 911 Bypass Rd Bldg A, Pikeville, KY 41501-1689 Ph: (606) 430-3500 |
News Archive
Treatments for childhood cancer have resulted in a current overall cure rate of over 70 percent. However, long-term survivors of childhood cancer are at a higher risk of developing a secondary cancer than the general population.
The microbial communities that reside in the human gut and their impact on human health and disease are one of the most exciting new areas of research today. To address the most recent advances in this rapidly developing field, scientists and health-care professionals from all over the world will come together at the Gut Microbiota for Health World Summit in Miami, Florida, on March 8 and 9, 2014.
EpiCept Corporation announced today that EpiCeptTM NP-1 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of post-herpetic neuralgia (PHN). NP-1 is a prescription topical analgesic cream designed to provide long-term relief from the pain of peripheral neuropathies.
Researchers from China have shown that a non-invasive method of measuring inspiratory muscle strength accurately reflects the severity of chronic obstructive pulmonary disease.
The release of the first draft of the National Alzheimer's Plan is another positive step toward the nation's first ever strategic plan for Alzheimer's.
› Verified 7 days ago
Matthew Sexton, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-1033 | |
Michael Albert Mcclain, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 | |
Dr. William E Duvall, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd Bldg A, Pikeville, KY 41501 Phone: 606-430-3500 Fax: 606-437-1033 | |
Kellie J Stivers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 | |
Dr. Philip S. Koerper, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-218-4562 | |
James Chumbley Crouch, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 Fax: 606-437-1033 | |
Dr. John Stuart Puckett, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 911 Bypass Rd, Pikeville, KY 41501 Phone: 606-218-3500 |